Back to Search
Start Over
Natriuretic Peptides as Inclusion Criteria in Clinical Trials
- Source :
- JACC: Heart Failure. 8:347-358
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Highlights •BNP and NT-proBNP are used as inclusion criteria in several HF clinical trials. •Despite widespread use, there is inconsistency in how BNP and NT-proBNP are utilized. •We call for standardization of natriuretic peptide inclusion criteria across HF trials.
- Subjects :
- medicine.medical_specialty
business.industry
medicine.drug_class
030204 cardiovascular system & hematology
medicine.disease
Clinical trial
03 medical and health sciences
0302 clinical medicine
Heart failure
medicine
Natriuretic peptide
Position paper
cardiovascular diseases
030212 general & internal medicine
Cardiology and Cardiovascular Medicine
Intensive care medicine
business
human activities
Inclusion (education)
hormones, hormone substitutes, and hormone antagonists
Subjects
Details
- ISSN :
- 22131779
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- JACC: Heart Failure
- Accession number :
- edsair.doi...........10f02445d3b14d02afaaadb7bd3a3e84
- Full Text :
- https://doi.org/10.1016/j.jchf.2019.12.010